BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 30905257)

  • 1. Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis.
    Fukuda D; Nishimoto S; Aini K; Tanaka A; Nishiguchi T; Kim-Kaneyama JR; Lei XF; Masuda K; Naruto T; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Kusunose K; Yamada H; Soeki T; Imoto I; Akasaka T; Shimabukuro M; Sata M
    J Am Heart Assoc; 2019 Apr; 8(7):e010860. PubMed ID: 30905257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
    Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
    Koulis C; Chen YC; Hausding C; Ahrens I; Kyaw TS; Tay C; Allen T; Jandeleit-Dahm K; Sweet MJ; Akira S; Bobik A; Peter K; Agrotis A
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):516-25. PubMed ID: 24436372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.
    Du F; Yu F; Wang Y; Hui Y; Carnevale K; Fu M; Lu H; Fan D
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):759-67. PubMed ID: 24504735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.
    Xu XH; Shah PK; Faure E; Equils O; Thomas L; Fishbein MC; Luthringer D; Xu XP; Rajavashisth TB; Yano J; Kaul S; Arditi M
    Circulation; 2001 Dec; 104(25):3103-8. PubMed ID: 11748108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STING, a cytosolic DNA sensor, plays a critical role in atherogenesis: a link between innate immunity and chronic inflammation caused by lifestyle-related diseases.
    Pham PT; Fukuda D; Nishimoto S; Kim-Kaneyama JR; Lei XF; Takahashi Y; Sato T; Tanaka K; Suto K; Kawabata Y; Yamaguchi K; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Shimada K; Kanematsu Y; Takagi Y; Shimabukuro M; Setou M; Barber GN; Sata M
    Eur Heart J; 2021 Nov; 42(42):4336-4348. PubMed ID: 34226923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
    Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronic Cigarettes Induce Mitochondrial DNA Damage and Trigger TLR9 (Toll-Like Receptor 9)-Mediated Atherosclerosis.
    Li J; Huynh L; Cornwell WD; Tang MS; Simborio H; Huang J; Kosmider B; Rogers TJ; Zhao H; Steinberg MB; Thu Thi Le L; Zhang L; Pham K; Liu C; Wang H
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):839-853. PubMed ID: 33380174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis.
    Borst O; Schaub M; Walker B; Schmid E; Münzer P; Voelkl J; Alesutan I; Rodríguez JM; Vogel S; Schoenberger T; Metzger K; Rath D; Umbach A; Kuhl D; Müller II; Seizer P; Geisler T; Gawaz M; Lang F
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):547-57. PubMed ID: 25614279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.
    Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Nishimoto S; Yagi S; Yamada H; Soeki T; Wakatsuki T; Shimabukuro M; Sata M
    Atherosclerosis; 2015 Oct; 242(2):639-46. PubMed ID: 25817329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
    Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
    Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
    Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
    Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
    Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
    Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Role of C3aR (C3a Anaphylatoxin Receptor) Against Atherosclerosis in Atherosclerosis-Prone Mice.
    Wei LL; Ma N; Wu KY; Wang JX; Diao TY; Zhao SJ; Bai L; Liu E; Li ZF; Zhou W; Chen D; Li K
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2070-2083. PubMed ID: 32762445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATRQβ-001 vaccine prevents atherosclerosis in apolipoprotein E-null mice.
    Zhou Y; Wang S; Qiu Z; Song X; Pan Y; Hu X; Zhang H; Deng Y; Ding D; Wu H; Yang S; Wang M; Zhou Z; Liao Y; Chen X
    J Hypertens; 2016 Mar; 34(3):474-85; discussion 485. PubMed ID: 26771341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression.
    Blich M; Golan A; Arvatz G; Sebbag A; Shafat I; Sabo E; Cohen-Kaplan V; Petcherski S; Avniel-Polak S; Eitan A; Hammerman H; Aronson D; Axelman E; Ilan N; Nussbaum G; Vlodavsky I
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):e56-65. PubMed ID: 23162016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
    Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K
    Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-188-3p upregulation results in the inhibition of macrophage proinflammatory activities and atherosclerosis in ApoE-deficient mice.
    Zhang XF; Yang Y; Yang XY; Tong Q
    Thromb Res; 2018 Nov; 171():55-61. PubMed ID: 30253270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2X
    Peikert A; König S; Suchanek D; Rofa K; Schäfer I; Dimanski D; Karnbrock L; Bulatova K; Engelmann J; Hoppe N; Wadle C; Heidt T; Albrecht P; von Garlen S; Härdtner C; Hilgendorf I; Wolf D; von Zur Mühlen C; Bode C; Zirlik A; Duerschmied D; Merz J; Stachon P
    Sci Rep; 2022 Feb; 12(1):2801. PubMed ID: 35181718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.